(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures were higher on Wednesday, after Apple reported strong quarterly results and ahead of a statement from the Federal Reserve. Dow Jones industrial average e-mini futures were up 0.11 percent at 17,533, S&P 500 e-mini futures were up 0.15 percent at 2,063.5 and Nasdaq 100 e-mini futures were up 0.18 percent at 4,640.75.
** APPLE INC, Tuesday close $114.55, +1.61 pct premarket
The iphone maker painted a rosy picture for its new iPhones as it reported quarterly results on Tuesday, but investors were more focused on the company’s next test: topping last year’s record holiday sales.
Breakingviews-Apple: a tech company with Chinese characteristics
Breakingviews-Searching for China consumer bellwethers is futile
** WALGREENS BOOTS ALLIANCE INC, Tuesday close $95.16, -2.22 pct premarket
** RITE AID CORP, Tuesday close $8.67, -7.38 pct premarket
Drugstore chain operator Walgreens, which agreed to buy smaller rival Rite Aid on Tuesday, reported a better-than-expected quarterly profit, helped by lower costs achieved through its cost-cutting plan.
Breakingviews-Investors coax Walgreens Boots to swallow Rite Aid
** TWITTER INC, Tuesday close $31.34, -10.31 pct premarket
The company gave a disappointing revenue forecast and reported slower user growth than expected. The forecast, which came even as Twitter beat third-quarter profit and revenue estimates, suggested that more time is needed for a turnaround as social media competition grows from the likes of Facebook Inc’s Instagram and Messenger apps. 12 brokerages cut price targets, Stifel upgrades to “buy” from “neutral”
** NORTHROP GRUMMAN CORP, Tuesday close $180.6, +5.73 pct premarket
Hours after winning a multibillion-dollar contract to build a new U.S. bomber, the company on Wednesday reported higher-than-expected quarterly revenues and earnings and increased its profit outlook for the full year.
** GILEAD SCIENCES INC, Tuesday close $110.96, -2.33 pct premarket
The drugmaker on Tuesday said its quarterly profit rose 70 percent, but sales growth for its hepatitis C drugs flattened as health insurers limited access to the expensive treatments.
** BOSTON SCIENTIFIC CORP, Tuesday close $16.82, +4.04 pct premarket
The medical device maker reported a better-than-expected quarterly profit, and raised its full-year profit forecast, as it expects a pick up in sales due to new devices.
** DIAMOND FOODS INC, Tuesday close $34.89, +5.76 pct premarket
Snack food maker Snyder’s-Lance Inc said it will buy Diamond Foods for about $1.27 billion to expand in the “better-for-you” foods category, which includes baked potato chips and fat-free popcorn.
** MACROCURE LTD, Tuesday close $4.26, -63.62 pct premarket
The Israeli biotechnology company said it would “analyze all strategic options” after its cell therapy for hard-to-treat wounds failed a late-stage U.S. study.
** GENERAL DYNAMICS CORP, Tuesday close $148.4, +1.08 pct premarket
The maker of Gulfstream jets, tanks and U.S. Navy ships, reported better-than-expected quarterly profit and revenue, partly helped by higher aircraft sales.
** STARWOOD HOTELS & RESORTS WORLDWIDE INC, Tuesday close $74.81, +0.70 pct premarket
** INTERVAL LEISURE GROUP, Tuesday close $20.77
Interval Leisure said it would buy hotel operator Starwood Hotels & Resorts Worldwide’s vacation ownership business, which it valued at about $1.5 billion.
** VALERO ENERGY CORP, Tuesday close $62.46, +0.86 pct premarket
The U.S. refiner reported a better-than-expected quarterly profit, helped by robust demand for refined products and lower crude costs.
** HERSHEY CO, Tuesday close $94.33, -2.62 pct premarket
The chocolate maker cut its full-year profit forecast, hurt by weak demand in North America and higher marketing costs ahead of the holiday season.
** GLAXOSMITHKLINE, Tuesday close $41.75, +3.64 pct premarket
The drugmaker reported better-than-expected quarterly earnings, helped by strong demand for HIV drugs and flu vaccines, which offset a continued slide in sales of respiratory medicine, sending its share 4 percent higher.
** VALEANT PHARMACEUTICALS INTERNATIONAL, Tuesday close $109.54
Activist firm ValueAct is meeting with other large investors in the Canadian drugmaker, as the company aims to rally support amid allegations of improper accounting and aggressive pricing.
** ARENA PHARMACEUTICALS INC, Tuesday close $2.2
The drug developer will shelve some trials related to its weight-loss drug and lay off about 80 employees, or 35 percent of its U.S. workforce, to cut costs and focus on other drugs under development.
** ANTHEM INC, Tuesday close $144.69
The health insurer reported a better-than-expected profit in the third quarter as more people enrolled for its government plans, especially Medicaid.
** HESS CORP, Tuesday close $56.93
The oil producer reported a net loss for the fourth quarter in a row, hurt by a 60 percent slump in crude prices over the past year.
** INTERCONTINENTAL EXCHANGE INC, Tuesday close $255.71
The exchange and clearing house operator reported a 49 percent jump in quarterly profit, helped by revenue from trading and listing fees and cost cuts.
Reporting by Rosmi Shaji in Bengaluru; Editing by Sriraj Kalluvila